Exploration of the precision of classifying sudden cardiac death. Implications for the interpretation of clinical trials
- PMID: 8565170
- DOI: 10.1161/01.cir.93.3.519
Exploration of the precision of classifying sudden cardiac death. Implications for the interpretation of clinical trials
Abstract
Background: As cardiovascular clinical trials improve in sophistication and therapies target specific cardiac mechanisms of death, a more objective and precise system to identify specific cause of death is needed. Ideally, sudden cardiac death would describe patients dying of ventricular tachycardia and ventricular fibrillation. In this context, we explored the precision of current sudden death classification and implications for clinical trials.
Methods and results: Deaths were analyzed in 834 patients who received an automatic implantable cardioverter-defibrillator (ICD). Three arrhythmia experts used a standard prospective classification system to classify deaths into accepted categories: sudden cardiac, nonsudden cardiac, and noncardiac. New aspects to this study included analysis of autopsy results and ICD interrogation for arrhythmias at the time of death. All of the patients receiving the ICD previously had documented sustained ventricular tachycardia/fibrillation or cardiac arrest. Of the 109 subsequent deaths in the 834-patient database, 17 (16%) were classified as sudden cardiac. Compared with the nonsudden cardiac and noncardiac categories, sudden cardiac death was more often identified in outpatients (59% versus 10%) and witnessed less often (41% versus 86%; both P < .001). The autopsy information contradicted and changed the clinical perception of a "sudden cardiac death" in 7 cases (myocardial infarction [n = 1], pulmonary embolism [n = 2], cerebral infarction [n = 1], ruptured thoracic [n = 1], and abdominal aortic aneurysms [n = 2]). Interpretable ICD interrogation was available in 53% of the deaths (47% unavailable: buried, programmed off, or other technical reasons). When evaluated, only 7 of 17 "sudden deaths" were associated with ICD discharges near the time of death.
Conclusions: Even in a group of patients with an ICD, deaths classified as sudden cardiac frequently were not associated with ventricular tachycardia or ventricular fibrillation and were often noncardiac. It is possible to create a wide range of sudden cardiac death rates (more than fourfold) using the identical clinical database despite objective, prespecified criteria. Autopsy results frequently reveal noncardiac causes of clinical events simulating sudden cardiac death. ICD interrogation revealed that ICD discharges were often related to terminal arrhythmias incidental to the primary pathophysiological process leading to death.
Similar articles
-
Sudden Death in Patients With Cardiac Implantable Electronic Devices.JAMA Intern Med. 2015 Aug;175(8):1342-50. doi: 10.1001/jamainternmed.2015.2641. JAMA Intern Med. 2015. PMID: 26098676
-
Implantable cardioverter-defibrillator therapy: influence of left ventricular function on long-term results.J Interv Card Electrophysiol. 1997 Nov;1(3):211-20. doi: 10.1023/a:1009716822824. J Interv Card Electrophysiol. 1997. PMID: 9869974
-
Secondary prevention of sudden death: the Dutch Study, the Antiarrhythmics Versus Implantable Defibrillator Trial, the Cardiac Arrest Study Hamburg, and the Canadian Implantable Defibrillator Study.Am J Cardiol. 1999 Mar 11;83(5B):68D-73D. doi: 10.1016/s0002-9149(98)01006-6. Am J Cardiol. 1999. PMID: 10089843 Review.
-
Sudden death in implantable cardioverter-defibrillator recipients: clinical context, arrhythmic events and device responses.J Am Coll Cardiol. 1999 Jan;33(1):24-32. doi: 10.1016/s0735-1097(98)00519-1. J Am Coll Cardiol. 1999. PMID: 9935004
-
Implantable cardioverter defibrillators in arrhythmogenic right ventricular dysplasia/cardiomyopathy: patient outcomes, incidence of appropriate and inappropriate interventions, and complications.Circ Arrhythm Electrophysiol. 2013 Jun;6(3):562-8. doi: 10.1161/CIRCEP.113.000392. Epub 2013 May 14. Circ Arrhythm Electrophysiol. 2013. PMID: 23673907 Review.
Cited by
-
Risk stratification and epidemiology of sudden death.Curr Cardiol Rep. 2004 Sep;6(5):333-8. doi: 10.1007/s11886-004-0035-6. Curr Cardiol Rep. 2004. PMID: 15306089 Review.
-
Socio-economic analysis of cardiac resynchronization therapy.J Interv Card Electrophysiol. 2006 Dec;17(3):225-36. doi: 10.1007/s10840-006-9079-4. Epub 2007 Mar 20. J Interv Card Electrophysiol. 2006. PMID: 17372813 Review.
-
Fighting against sudden death: a single or multidisciplinary approach.J Interv Card Electrophysiol. 2006 Dec;17(3):205-10. doi: 10.1007/s10840-006-9077-6. Epub 2007 Apr 6. J Interv Card Electrophysiol. 2006. PMID: 17415628 Review.
-
ECG quantification of myocardial scar and risk stratification in MADIT-II.Ann Noninvasive Electrocardiol. 2013 Sep;18(5):427-35. doi: 10.1111/anec.12065. Epub 2013 Jun 9. Ann Noninvasive Electrocardiol. 2013. PMID: 24047486 Free PMC article. Clinical Trial.
-
Preventing sudden death in the adult with congenital heart disease.Curr Cardiol Rep. 2011 Aug;13(4):327-35. doi: 10.1007/s11886-011-0189-y. Curr Cardiol Rep. 2011. PMID: 21559945 Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials